Acetylcholine and the alpha 7 nicotinic receptor: a potential therapeutic target for the treatment of periodontal disease?
about
Targeting the non-neuronal cholinergic system in macrophages for the management of infectious diseases and cancer: challenge and promiseActivation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production.The alpha 7 nicotinic receptor agonist PHA-543613 hydrochloride inhibits Porphyromonas gingivalis-induced expression of interleukin-8 by oral keratinocytesNew strategic insights into managing fungal biofilmsResearch tool: Validation of floxed α7 nicotinic acetylcholine receptor conditional knockout mice using in vitro and in vivo approaches.The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.
P2860
Acetylcholine and the alpha 7 nicotinic receptor: a potential therapeutic target for the treatment of periodontal disease?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Acetylcholine and the alpha 7 ...... atment of periodontal disease?
@en
type
label
Acetylcholine and the alpha 7 ...... atment of periodontal disease?
@en
prefLabel
Acetylcholine and the alpha 7 ...... atment of periodontal disease?
@en
P2860
P1476
Acetylcholine and the alpha 7 ...... atment of periodontal disease?
@en
P2093
David F Lappin
Noha Zoheir
P2860
P2888
P304
P356
10.1007/S00011-012-0513-Z
P577
2012-07-10T00:00:00Z
P5875
P6179
1019976257